Tech Company Financing Transactions

Trimtech Therapeutics Funding Round

On 6/23/2026, Trimtech Therapeutics raised $14 million in Seed funding from BGF Ventures, Cambridge Enterprise and Cambridge Innovation Capital.

Transaction Overview

Announced On
6/23/2026
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge B
Cambridge, CB2 0AW
UK
Email Address
Not Recorded
Overview
At TRIMTECH Therapeutics our mission is to create novel, highly differentiated, orally active small molecule degraders of protein aggregates that will combat major neurodegenerative and inflammatory disorders with a significant medical need.
Profile
Trimtech Therapeutics LinkedIn Company Profile
Social Media
Trimtech Therapeutics Company Twitter Account
Company News
Trimtech Therapeutics News
Facebook
Trimtech Therapeutics on Facebook
YouTube
Trimtech Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Nicki Thompson
  Nicki Thompson LinkedIn Profile  Nicki Thompson Twitter Account  Nicki Thompson News  Nicki Thompson on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/23/2026: Orderful venture capital transaction
Next: 6/23/2026: Partly venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary